HomeCompareKLSVF vs ABBV

KLSVF vs ABBV: Dividend Comparison 2026

KLSVF yields 1000.00% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KLSVF wins by $18844438.58M in total portfolio value
10 years
KLSVF
KLSVF
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full KLSVF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — KLSVF vs ABBV

📍 KLSVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKLSVFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KLSVF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KLSVF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KLSVF
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, KLSVF beats the other by $13,384,783,373,446.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KLSVF + ABBV for your $10,000?

KLSVF: 50%ABBV: 50%
100% ABBV50/50100% KLSVF
Portfolio after 10yr
$9422219.39M
Annual income
$7,873,402,009,152.06/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

KLSVF
No analyst data
Altman Z
-2.2
Piotroski
2/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KLSVF buys
0
ABBV buys
0
No recent congressional trades found for KLSVF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKLSVFABBV
Forward yield1000.00%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.6%
Portfolio after 10y$18844438.68M$102.3K
Annual income after 10y$15,746,803,993,532.36$24,771.77
Total dividends collected$18607754.73M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KLSVF vs ABBV ($10,000, DRIP)

YearKLSVF PortfolioKLSVF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$110,700$100,000.00$11,550$430.00+$99.2KKLSVF
2$1,153,028$1,034,579.44$13,472$627.96+$1.14MKLSVF
3$11,304,737$10,070,996.94$15,906$926.08+$11.29MKLSVF
4$104,376,400$92,280,331.11$19,071$1,382.55+$104.36MKLSVF
5$907,965,307$796,282,558.81$23,302$2,095.81+$907.94MKLSVF
6$7,445,190,031$6,473,667,152.78$29,150$3,237.93+$7445.16MKLSVF
7$57,576,798,154$49,610,444,821.11$37,536$5,121.41+$57576.76MKLSVF
8$420,166,535,918$358,559,361,892.40$50,079$8,338.38+$420166.49MKLSVF
9$2,894,985,686,808$2,445,407,493,376.48$69,753$14,065.80+$2894985.62MKLSVF
10$18,844,438,678,417$15,746,803,993,532.36$102,337$24,771.77+$18844438.58MKLSVF

KLSVF vs ABBV: Complete Analysis 2026

KLSVFStock

Klondike Silver Corp., a resource exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Canada. It primarily explores for silver, lead, and zinc deposits. The company primarily owns a 100% interest in the Slocan Silver camp that covers an area of approximately 116 square kilometers located in south-eastern British Columbia. Klondike Silver Corp. was incorporated in 2005 and is based in Vancouver, Canada.

Full KLSVF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this KLSVF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KLSVF vs SCHDKLSVF vs JEPIKLSVF vs OKLSVF vs KOKLSVF vs MAINKLSVF vs JNJKLSVF vs MRKKLSVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.